David Braun's Blog

Is Everyone on the Same Page? Gaining Clarity on Your Company’s Vision for Growth

“We have a strong vision and a clear plan for growing the company in the future,” Sarah, the CEO, told me with complete confidence during a recent strategy session. Her CFO disagreed: “We have no vision.” Various members of her executive team shared similar sentiments privately with my team and me. Many expressed anxiety; they

Read more ...
Valeant Acquires Salix in the Latest Wave of Pharmaceutical M&A

Yesterday, Salix Pharmaecuticals accepted Valeant’s raised takeover offer of $10.96 billion in cash, ending the bidding war between Endo and Valeant for the gastrointestinal drug maker. Valeant’s new offer of $173 per share is about a 10% increase over its original offer of $158 per share. Valeant also paid $296 million for assets of bankrupt

Read more ...